NCT06991816

Brief Summary

The aim of this longitudinal observational study is to evaluate the impact of sensory deficits (smell, hearing and balance on cognitive decline and quality of life in the medium term (5 years)) on a population of patients over 55. Patients will be evaluated by a neurologist, a neuropsychologist and an otolaryngologist who will perform olfactory, auditory and vestibular tests. The acquired data will then be analyzed with multivariate analysis to understand the effect of multisensory deficit on both cognition and quality of life with a particular focus on depression. The primary objective will be the evaluation of multiple deficits on cognition, the secondary will be aimed at understanding whether one sensory deficit more than another, e.g. smell versus hearing, will have a greater impact on the patient's conditions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
63mo left

Started Aug 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Aug 2025Jun 2031

First Submitted

Initial submission to the registry

March 24, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 28, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
4.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2031

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

March 24, 2025

Last Update Submit

April 22, 2026

Conditions

Keywords

Cognitive DeclineSmell LossVertigo/ DizzinessHearing Loss

Outcome Measures

Primary Outcomes (1)

  • Impact of hearing loss, vertigo and smell loss on cognition

    All these measures are numeric. Vertigo will be yes (1) or no (0), same for hearing loss and smell loss

    5 years

Other Outcomes (3)

  • Hearing Loss

    each year for 5 years

  • Smell loss

    each year for 5 years

  • Vertigo

    each year for 5 years

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients affected by mild cognitive impairment (MCI), Alzheimer Disease in Early stage, Parkison Disease in early stage

You may qualify if:

  • Patients between 60 and 85 years of age
  • in general good health
  • the absence of known severe psychiatric disorders
  • available to be included in the study and
  • to follow the 5-year follow-up.

You may not qualify if:

  • Obstructive nasal problems
  • Previous endoscopic nose + paranasal sinus surgery
  • Chronic use of cortisone spray and/or systemic
  • Subjects with previous stroke and outcomes
  • Subjects with history of stroke in the last 3 years without outcomes
  • Head trauma in the last 24 months
  • Previous ear surgery
  • Patients who have been exposed to chemical agents without protection for work, e.g. carpenters
  • previous Covid with outcomes (olfactory, vestibular, auditory and cognitive "brain fog")

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanvitelli ENT department

Naples, Campania, 80138, Italy

Location

Related Publications (12)

  • Myrstad C, Engdahl BL, Costafreda SG, Krokstad S, Lin F, Livingston G, Strand BH, Ohre B, Selbaek G. Hearing impairment and risk of dementia in The HUNT Study (HUNT4 70+): a Norwegian cohort study. EClinicalMedicine. 2023 Dec 4;66:102319. doi: 10.1016/j.eclinm.2023.102319. eCollection 2023 Dec.

    PMID: 38192588BACKGROUND
  • O'Malley PG. Evolving insights about the impact of sensory deficits in the elderly: comment on "The prevalence of concurrent hearing and vision impairment in the United states" and "Hearing loss and cognitive decline in older adults". JAMA Intern Med. 2013 Feb 25;173(4):299. doi: 10.1001/jamainternmed.2013.3760. No abstract available.

  • Rong H, Lai X, Jing R, Wang X, Fang H, Mahmoudi E. Association of Sensory Impairments With Cognitive Decline and Depression Among Older Adults in China. JAMA Netw Open. 2020 Sep 1;3(9):e2014186. doi: 10.1001/jamanetworkopen.2020.14186.

  • Mahmoudi E. Hearing, Vision, or Dual Sensory Impairment and Dementia Risk. JAMA Netw Open. 2021 Mar 1;4(3):e211846. doi: 10.1001/jamanetworkopen.2021.1846. No abstract available.

  • Liljas AEM, Jones A, Cadar D, Steptoe A, Lassale C. Association of Multisensory Impairment With Quality of Life and Depression in English Older Adults. JAMA Otolaryngol Head Neck Surg. 2020 Mar 1;146(3):278-285. doi: 10.1001/jamaoto.2019.4470.

  • Stickel AM, Mendoza A, Tarraf W, Kuwayama S, Kaur S, Morlett Paredes A, Daviglus ML, Testai FD, Zeng D, Isasi CR, Baiduc RR, Dinces E, Lee DJ, Gonzalez HM. Hearing Loss and Associated 7-Year Cognitive Outcomes Among Hispanic and Latino Adults. JAMA Otolaryngol Head Neck Surg. 2024 May 1;150(5):385-392. doi: 10.1001/jamaoto.2024.0184.

  • An YY, Lee ES, Lee SA, Choi JH, Park JM, Lee TK, Kim H, Lee JD. Association of Hearing Loss With Anatomical and Functional Connectivity in Patients With Mild Cognitive Impairment. JAMA Otolaryngol Head Neck Surg. 2023 Jul 1;149(7):571-578. doi: 10.1001/jamaoto.2023.0824.

  • Lee EY, Eslinger PJ, Du G, Kong L, Lewis MM, Huang X. Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease. Mov Disord. 2014 Aug;29(9):1205-8. doi: 10.1002/mds.25829. Epub 2014 Jan 30.

  • Kollndorfer K, Jakab A, Mueller CA, Trattnig S, Schopf V. Effects of chronic peripheral olfactory loss on functional brain networks. Neuroscience. 2015 Dec 3;310:589-99. doi: 10.1016/j.neuroscience.2015.09.045. Epub 2015 Sep 28.

  • Lin FR, Ferrucci L. Hearing loss and falls among older adults in the United States. Arch Intern Med. 2012 Feb 27;172(4):369-71. doi: 10.1001/archinternmed.2011.728. No abstract available.

  • Vohra V, Simonsick EM, Kamath V, Bandeen-Roche K, Agrawal Y, Rowan NR. Physical Function Trajectories and Mortality in Older Adults With Multisensory Impairment. JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):217-225. doi: 10.1001/jamaoto.2023.4378.

  • Di Stadio A, Ralli M, Kaski D. Multisensory Rehabilitation in Older Adults to Improve Longevity and Wellness. JAMA Otolaryngol Head Neck Surg. 2024 Aug 1;150(8):748-749. doi: 10.1001/jamaoto.2024.1695. No abstract available.

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseAnosmiaHearing Loss

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesOlfaction DisordersSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHearing DisordersEar DiseasesOtorhinolaryngologic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Otolaryngology

Study Record Dates

First Submitted

March 24, 2025

First Posted

May 28, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

June 30, 2031

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations